This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 57558636-f967-403c-9009-59ca4bd1
Credit: Unsplash/CC0 Public Domain In two trials, one in frail elderly patients, evening administration of BP-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in
New research from RCSI University of Medicine and Health Sciences has provided greater insight into the causes of Long COVID syndrome. The findings, which further investigate the link between Long
Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and
